Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLDX | CELLDEX THERAPEUTICS INC | $2.12B | $37.98 | $66.00 | 73.78% | Strong Buy | 4 | -2.54% | N/A | N/A | N/A | ||||
| OLMA | OLEMA PHARMACEUTICALS INC | $555.23M | $9.93 | $22.50 | 126.59% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| MXCT | MAXCYTE INC | $411.31M | $3.95 | $8.67 | 119.42% | Strong Buy | 3 | -17.29% | N/A | N/A | N/A | ||||
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | $1.31B | $14.96 | $38.25 | 155.68% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| GEF | GREIF INC | $2.89B | $61.36 | $80.00 | 30.38% | Strong Buy | 3 | 6.54% | N/A | N/A | N/A | ||||
| TRML | TOURMALINE BIO INC | $396.24M | $15.45 | $61.80 | 300.00% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| DNTH | DIANTHUS THERAPEUTICS INC | $682.31M | $23.25 | $41.75 | 79.57% | Strong Buy | 4 | -0.85% | N/A | N/A | N/A | ||||
| SNDX | SYNDAX PHARMACEUTICALS INC | $1.77B | $20.80 | $34.67 | 66.67% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| ACDC | PROFRAC HOLDING CORP | $1.29B | $8.11 | $11.17 | 37.69% | Strong Buy | 3 | 5.68% | N/A | N/A | N/A | ||||
| IMVT | IMMUNOVANT INC | $4.10B | $28.22 | $51.90 | 83.91% | Strong Buy | 10 | N/A | N/A | N/A | N/A | ||||
| SVRA | SAVARA INC | $664.49M | $4.81 | $9.25 | 92.31% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| MYPS | PLAYSTUDIOS INC | $314.64M | $2.31 | $4.33 | 87.58% | Strong Buy | 3 | 3.80% | N/A | N/A | N/A | ||||
| DCO | DUCOMMUN INC | $761.63M | $52.02 | $65.67 | 26.23% | Strong Buy | 3 | 4.77% | N/A | N/A | N/A | ||||
| TYL | TYLER TECHNOLOGIES INC | $17.05B | $403.35 | $494.29 | 22.55% | Strong Buy | 7 | 8.77% | N/A | N/A | N/A | ||||
| OMCL | OMNICELL INC | $1.28B | $27.83 | $34.33 | 23.37% | Strong Buy | 3 | -2.15% | N/A | N/A | N/A | ||||
| ACRV | ACRIVON THERAPEUTICS INC | $212.56M | $9.39 | $16.50 | 75.72% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| IVA | INVENTIVA SA | $173.55M | $3.33 | $22.33 | 570.66% | Strong Buy | 3 | -1.30% | N/A | N/A | N/A | ||||
| CMPS | COMPASS PATHWAYS PLC | $538.23M | $8.38 | $55.33 | 560.30% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| KC | KINGSOFT CLOUD HOLDINGS LTD | $632.45M | $2.65 | $4.35 | 64.15% | Strong Buy | 4 | 4.07% | N/A | N/A | N/A | ||||
| VYGR | VOYAGER THERAPEUTICS INC | $407.25M | $7.50 | $20.50 | 173.33% | Strong Buy | 4 | -25.11% | N/A | N/A | N/A | ||||
| TBBB | BBB FOODS INC | N/A | $19.90 | $29.00 | 45.73% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| STNG | SCORPIO TANKERS INC | $3.69B | $69.53 | $89.00 | 28.00% | Strong Buy | 3 | -6.40% | N/A | N/A | N/A | ||||
| VKTX | VIKING THERAPEUTICS INC | $6.37B | $63.42 | $112.25 | 76.99% | Strong Buy | 8 | N/A | N/A | N/A | N/A | ||||
| BKR | BAKER HUGHES CO | $32.63B | $32.60 | $40.50 | 24.23% | Strong Buy | 4 | 7.13% | 4.06% | N/A | N/A | ||||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $235.36M | $11.34 | $33.33 | 193.94% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| NOTE | FISCALNOTE HOLDINGS INC | $150.66M | $1.15 | $3.50 | 204.35% | Strong Buy | 4 | -6.18% | N/A | N/A | N/A | ||||
| GM | GENERAL MOTORS CO | $48.91B | $42.37 | $53.41 | 26.05% | Strong Buy | 13 | 0.42% | -15.06% | N/A | N/A | ||||
| APTO | APTOSE BIOSCIENCES INC | $19.35M | $1.23 | $15.33 | 1,145.57% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| STLA | STELLANTIS NV | $77.91B | $25.77 | $31.93 | 23.92% | Strong Buy | 3 | 1.17% | -52.51% | N/A | N/A | ||||
| LPTX | LEAP THERAPEUTICS INC | $71.68M | $2.80 | $11.38 | 306.25% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| RGTI | RIGETTI COMPUTING INC | $174.77M | $1.10 | $3.17 | 187.91% | Strong Buy | 3 | N/A | N/A | -43.49% | -29.81% | ||||
| NUVL | NUVALENT INC | $4.02B | $62.76 | $101.83 | 62.26% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| OUST | OUSTER INC | $291.21M | $7.16 | $10.00 | 39.66% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| NR | NEWPARK RESOURCES INC | $629.64M | $7.39 | $10.75 | 45.47% | Strong Buy | 4 | -4.70% | N/A | N/A | N/A | ||||
| DAL | DELTA AIR LINES INC | $30.70B | $47.57 | $62.80 | 32.02% | Strong Buy | 5 | 2.40% | -4.51% | N/A | N/A | ||||
| BIP | BROOKFIELD INFRASTRUCTURE PARTNERS LP | $12.53B | $27.16 | $37.33 | 37.46% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| TNGX | TANGO THERAPEUTICS INC | $780.11M | $7.31 | $17.00 | 132.56% | Strong Buy | 3 | 1.25% | N/A | N/A | N/A | ||||
| SYNA | SYNAPTICS INC | $3.19B | $81.04 | $124.88 | 54.09% | Strong Buy | 8 | -7.16% | N/A | N/A | N/A | ||||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $84.31M | $3.02 | $16.33 | 440.83% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| DNLI | DENALI THERAPEUTICS INC | $2.23B | $16.00 | $43.29 | 170.54% | Strong Buy | 7 | -10.37% | N/A | N/A | N/A | ||||
| HLVX | HILLEVAX INC | $611.32M | $12.30 | $30.67 | 149.33% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| KTB | KONTOOR BRANDS INC | $3.15B | $56.45 | $70.40 | 24.71% | Strong Buy | 5 | -0.21% | N/A | N/A | N/A | ||||
| ABUS | ARBUTUS BIOPHARMA CORP | $488.22M | $2.72 | $4.33 | 59.30% | Strong Buy | 3 | -15.54% | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.